Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome

Non-alcoholic fatty liver disease (NAFLD) is estimated to affect 24% of the global adult population. NAFLD is a major risk factor for the development of cirrhosis and hepatocellular carcinoma, as well as being strongly associated with type 2 diabetes and cardiovascular disease. It has been proposed...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinton, Matthew C., Hay, David C., Drake, Amanda J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637519/
https://www.ncbi.nlm.nih.gov/pubmed/31319896
http://dx.doi.org/10.1186/s13148-019-0702-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637519/
https://www.ncbi.nlm.nih.gov/pubmed/31319896
http://dx.doi.org/10.1186/s13148-019-0702-5

Ejemplares similares